221 related articles for article (PubMed ID: 31983096)
21. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
22. MiR-520b inhibited metastasis and proliferation of non-small cell lung cancer by targeting CHAF1A.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7742-7749. PubMed ID: 30536318
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer.
Fu Y; Li Y; Wang X; Li F; Lu Y
Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046
[TBL] [Abstract][Full Text] [Related]
24. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
[TBL] [Abstract][Full Text] [Related]
25. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
26. Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4.
Chen T; Liu Y; Chen J; Zheng H; Chen Q; Zhao J
Thorac Cancer; 2021 Feb; 12(3):372-381. PubMed ID: 33350095
[TBL] [Abstract][Full Text] [Related]
27. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2.
Li G; Wu F; Yang H; Deng X; Yuan Y
Biomed Pharmacother; 2017 Dec; 96():1170-1178. PubMed ID: 29239816
[TBL] [Abstract][Full Text] [Related]
28. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN.
Akgun S; Kucuksayan H; Ozes ON; Can O; Alikanoglu AS; Yildiz M; Akca H
Anticancer Agents Med Chem; 2019; 19(8):1058-1068. PubMed ID: 30727918
[TBL] [Abstract][Full Text] [Related]
29. The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
Ma N; Zhang W; Qiao C; Luo H; Zhang X; Liu D; Zang S; Zhang L; Bai J
Cell Physiol Biochem; 2016; 38(4):1435-46. PubMed ID: 27035590
[TBL] [Abstract][Full Text] [Related]
30. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
Dao R; Wudu M; Hui L; Jiang J; Xu Y; Ren H; Qiu X
Pathol Res Pract; 2020 Mar; 216(3):152823. PubMed ID: 31983569
[TBL] [Abstract][Full Text] [Related]
32. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
[TBL] [Abstract][Full Text] [Related]
34. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
35. Kinesin family member 3C (KIF3C) is a novel non-small cell lung cancer (NSCLC) oncogene whose expression is modulated by microRNA-150-5p (miR-150-5p) and microRNA-186-3p (miR-186-3p).
Liu H; Liu R; Hao M; Zhao X; Li C
Bioengineered; 2021 Dec; 12(1):3077-3088. PubMed ID: 34193018
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
37. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
Zhu J; Zhang Y; Yang X; Jin L
Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
[TBL] [Abstract][Full Text] [Related]
38. miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.
Hong-Yuan W; Xiao-Ping C
Indian J Cancer; 2015 Dec; 52 Suppl 3():E168-71. PubMed ID: 27453416
[TBL] [Abstract][Full Text] [Related]
39. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
Li W; Cui Y; Wang D; Wang Y; Wang L
Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
[TBL] [Abstract][Full Text] [Related]
40. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
